Dr. Garfinkle will use state-of-the-art genomic technologies to study each individual tumor and immune cell in pediatric rhabdoid tumor patient samples and map the location of these cells in relation to one another, a resolution not previously achieved with traditional genomic studies.
published research
Kebede AM, Garfinkle EAR, Mathew MT, Varga E, Colace SI, Wheeler G, Kelly BJ, Schieffer KM, Miller KE, Mardis ER, Cottrell CE, Potter SL. Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center. Front Oncol. 2024.